Crystal structure of (5 R ,8 R ,9 R ,10 R ,12 R , 13 R ,14 R ,17 S )-2-( E -3-fluorobenzylidene)-12-hydroxy-4,4,8,10,14-pentamethyl-17-(( R )-2,6,6-trimethyltetrahydro-2 H -pyran-2-yl) hexadecahydro-3 H -cyclopenta[ a ]phenanthren-3-one, C 37 H 53 FO 3

Kuo Cheng,Ya-Bin Song,Qing-Guo Meng,Bao-Gang Wang,Yun Hou,Wen-Shui Wang,Sheng Jiang

DOI: https://doi.org/10.1515/ncrs-2023-0470

2024-01-14

Zeitschrift für Kristallographie - New Crystal Structures

Abstract:C 37 H 53 FO 3 , orthorhombic, P2 1 2 1 2 1 (no. 19), a = 7.4716(8) Å, b = 15.0009(15) Å, c = 28.065(5) Å, V = 3145.5(7) Å 3 , Z = 4, R gt (F) = 0.0643, wR ref (F 2 ) = 0.1464, T = 293 K.

crystallography

What problem does this paper attempt to address?

Crystal Structure of Ethyl 1-(4-fluorobenzyl)-3-phenyl-1h-pyrazole-5-carboxylate, C19H17FN2O2

Sheng-Yue Tong,Jin-Zong You,Yi-Ping Zhang,Zhen-Zhen Wang,Ke-Ji Yu,Qiong Hu,Hui-Juan Pan,Cheng-Jie Wu,De-Qiang Qi

DOI: https://doi.org/10.1515/ncrs-2017-0266

2018-01-01

Zeitschrift für Kristallographie - New Crystal Structures

Abstract:Abstract C19H17FN2O2, triclinic, P1̅ (no. 2), a = 7.8593(19) Å, b = 10.3322(18) Å, c = 10.9747(19) Å, α = 108.914(18)°, β = 92.931(3)°, γ = 99.544(3)°, V = 826.1(3) Å3, Z = 2, R gt(F) = 0.0431, wR ref(F 2) = 0.1170, T = 296.15 K.
Crystal structure of (8 R ,9 S ,10 R ,13 S ,14 S ,17 S )-17-hydroxy-10,13-dimethyl-17-((4-(2-phenylpropyl)phenyl)ethynyl)-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3 H -cyclopenta[ a ]phenanthren-3-one, C 36 H 42 O 2

Xinling Li,Weijie Deng,Yubing Huang,Jinhui Hu,Yibiao Li

DOI: https://doi.org/10.1515/ncrs-2024-0024

2024-03-15

Zeitschrift für Kristallographie - New Crystal Structures

Abstract:C 36 H 42 O 2 , monoclinic, P 2 1 / n (no. 4), a = 9.0092(8) Å, b = 9.4264(11) Å, c = 17.2712(16) Å, β = 96.156(8)°, V = 1458.3(3) Å 3 , Z = 2, R gt ( F ) = 0.0509, wR ref ( F 2 ) = 0.1272, T = 150.00(10) K.

crystallography
Crystal Structure of 2-(1-benzyl-3-phenyl-1h-pyrazol-5-yl)-5-(4-nitrobenzylthio)-1,3,4-oxadiazole, C25H19N5O3S

Xu-Wen Huang,Jin-Zong You,Wan-Min Ni,Yi-Ping Zhang,Qi Feng,Wen-Chang Xu,Sheng-Yue Tong,Tang-Qi Li,De-Qiang Qi

DOI: https://doi.org/10.1515/ncrs-2016-0262

2017-01-01

Zeitschrift für Kristallographie - New Crystal Structures

Abstract:C25H19N5O3S, monoclinic, P21/c (no. 14), a = 16.715(2) Å, b = 11.2677(15) Å, c = 12.6490(17) Å, β = 110.818(2)°, V = 2226.7(5) Å3, Z = 4, Rgt(F) = 0.0424, wRref(F2) = 0.1037, T = 296 K.
Crystal Structure of Methyl 1-(4-fluorobenzyl)-3phenyl-1h-pyrazole-5-carboxylate, C18h15fn2o2

Wen-Chang Xu,Jin-Zong You,Yi-Ping Zhang,Xu-Wen Huang,Tang-Qi Li,Sheng-Yue Tong,De-Qiang Qi

DOI: https://doi.org/10.1515/ncrs-2016-0268

2017-01-01

Abstract:C18H15FN2O2, triclinic, P1̅ (no. 2), a = 7.8272(8) Å, b = 9.6662(10) Å, c = 10.9834(12) Å, α = 107.859(2)°, β = 92.559(2)°, γ = 99.415(2)°, V = 776.31(14) Å3, Z = 2, Rgt(F) = 0.0407, wRref(F2) = 0.1187, T = 296 K.
The Crystal Structure of (E)-3-chloro-2-(2-(2-fluorobenzylidene)hydrazinyl)pyridine, C12H9ClFN3

Hui-Zhen Wu,Li-Jing Min,Liang Han,Xing-Hai Liu,Na-Bo Sun

DOI: https://doi.org/10.1515/ncrs-2021-0164

2021-01-01

Zeitschrift für Kristallographie - New Crystal Structures

Abstract:C12H9ClFN3, monoclinic, C2/c (no. 15), a = 24.713(13) Å, b = 15.459(13) Å, c = 17.507(12) Å, β = 17.515(11)°, V = 4742(6) Å3, Z = 16, Rgt(F) = 0.0530, wRref(F2) = 0.1161, T = 113(2) K.
Crystal Structure of Ethyl 1-Benzyl-5-phenyl-1h-pyrazole-3-carboxylate, C19h18n2o2

Wen-Chang Xu,Jin-Zong You,Qi Feng,Yi-Ping Zhang,Wan-Min Ni,Xu-Wen Huang,Tang-Qi Li,Sheng-Yue Tong,De-Qiang Qi

DOI: https://doi.org/10.1515/ncrs-2016-0261

2017-01-01

Abstract:C19H18N2O2, triclinic, P1̅ (no. 2), a = 9.832(2) Å, b = 10.590(2) Å, c = 17.794(3) Å, α = 77.080(3)°, β = 81.720(4)°, γ = 64.958(3)°, V = 1633.7(5) Å3, Z = 4, Rgt(F) = 0.0634, wRref(F2) = 0.1964, T = 296 K.
Crystal Structure of 3,3,4,4,5,5-Hexafluoro-{1-[2-methyl-5- (4-Formylphenyl)-thien-3-yl]-2-[2-methyl-5-(4-(1,3-dioxolan- 2-Yl)phenyl)-thien-3-yl]}-cyclopent-1-ene, C31H22F6O3S2

SZ Pu,Q Xiao,RJ Wang,JK Xu,L Shen,B Chen

DOI: https://doi.org/10.1524/ncrs.2005.220.14.265

2005-01-01

Zeitschrift für Kristallographie - New Crystal Structures

Abstract:C31H22F6O3S2, monoclinic, P12(1)/c1 (no. 14), a = 27.16(1) angstrom, b = 9.334(2) angstrom, c = 10.929(3) angstrom, beta = 92.10(3)degrees, V = 2768.4 angstrom(3), Z = 4, R-gt(F) = 0.128, wR(ref)(F-2) = 0. 199, T = 293 K.
Crystal structure of (2 S ,3 R ,4 S ,5 S ,6 R )-4,5-dihydroxy-6-(hydroxymethyl)-2-(((4 aS ,5 R ,6 S )-1-oxo-5-vinyl-4,4 a ,5,6-tetrahydro-1 H ,3 H -pyrano[3,4- c ]pyran-6-yl)oxy)tetrahydro-2 H -pyran-3-yl 2,3-dihydroxybenzoate hydrate, C 23 H 26 O 12 ·H 2 O

Xue Zeng,Yuanjiao Feng,Lei Shi,Wenwu Zhong,Yahui Niu

DOI: https://doi.org/10.1515/ncrs-2023-0538

2024-02-17

Zeitschrift für Kristallographie - New Crystal Structures

Abstract:C 23 H 26 O 12 ·H 2 O, orthorhombic, P 2 1 2 1 2 1 (no. 19), a = 6.2630(6) Å, b = 17.5649(18) Å, c = 21.929(2) Å, V = 2412.4(4) Å 3 , Z = 4, R gt ( F ) = 0.0381, wR ref ( F 2 ) = 0.1017, T = 296 K.

crystallography
Crystal Structure of (Z)-2-(4-((5-bromopentyl)oxy)benzylidene)-4,5,6-trimethoxybenzofuran-3(2h)-one, C23H25BrO6

Hua-Bin Wang,Long Xu,Jing-Min Shi,Ying Zhou,Yong‐Jia Hao

DOI: https://doi.org/10.1515/ncrs-2023-0329

2023-01-01

Abstract:C 23 H 25 BrO 6 , triclinic, P 1 ‾ $\overline{1}$ (no. 2), a = 7.8451(3) Å, b = 7.9428(2) Å, c = 17.6360(6) Å, α = 90.146(3), β = 90.433(3) ∘ , γ = 99.307(3) ∘ , V = 1084.44(7) Å 3 , Z = 2, R gt ( F ) = 0.0464, wR ref ( F 2 ) = 0.1402, T = 297.37(10) K.
Crystal structure of 7 2 ,7 3 ,7 5 ,7 6 -tetrafluoro-2 5 ,4 4 -dimethyl-3 1 ,3 3 ,3 6 ,3 8 -tetraoxo-3 1 ,3 2 ,3 3 ,3 6 ,3 7 ,3 8 -hexahydro-3(2,7)-benzo[ lmn ][3,8]phenanthrolina-1,5(4,1)-dipyridin-1-iuma-2,4(1,2),7(1,4)-tribenzenacyclooctaphane-1 1 ,5 1 -diium hexafluoridophosphate, [C 46 H 28 F 4 N 4 O 4 ][PF 6 ] 2 , a dicationic cyclophane

Xiuteng Wang,Wei Wei

DOI: https://doi.org/10.1515/ncrs-2024-0290

2024-11-01

Zeitschrift für Kristallographie - New Crystal Structures

Abstract:C 46 H 28 F 16 N 4 O 4 P 2 , monoclinic, P2 1 /n (no. 14), a = 9.3041(2) Å, b = 22.4679(5) Å, c = 19.9446(3) Å, β = 98.154(2)°, V = 4,127.14(14) Å 3 , Z = 4, R gt (F) = 0.0478, wR ref (F 2 ) = 0.1411, T = 173(2) K.

crystallography
Crystal Structure of 3,3,4,4,5,5-Hexafluoro-1,2-bis(5-(3-trifluorophenyl)-2-methyl-3-thienyl) -Cyclopent-1-ene,c29h16f12s2

SZ Pu,RJ Wang,L Shen,G Liu,JK Xu,Q Xiao,B Chen

DOI: https://doi.org/10.1524/ncrs.2005.220.14.81

2005-01-01

Abstract:C29H16F12S2, monoclinic, C12/cl (no. 15), a = 20.687(3) angstrom, b = 8.3928(9) angstrom, c = 16.568(2) angstrom, beta = 104.39(1)degrees, V = 2786.3 angstrom(3), Z = 4, R-gt(F) = 0.082, wR(ref)(F-2) = 0.164, T = 293 K.
Crystal structure of 4,8a-bis(4-chlorophenyl)-1,5,6-tris(4-fluorobenzyl)-1,4,4a,4b,5,6,8a,8b-octahydrocyclobuta[1,2- b :3,4- c ′]dipyridine-3,8-dicarbonitrile, C 45 H 33 Cl 2 F 3 N 4

Zhuo-Jun Li,Lu-Yao Xiao,Wei-Kang Shi,Kai-Yin Yang

DOI: https://doi.org/10.1515/ncrs-2024-0141

2024-06-01

Zeitschrift für Kristallographie - New Crystal Structures

Abstract:C 45 H 33 Cl 2 F 3 N 4 , monoclinic, P 2 1 / c (no. 14), a = 11.7076(13) Å, b = 11.8186(13) Å, c = 27.473(3) Å, β = 91.188(2)°, V = 3800.6(7) Å 3 , Z = 4, R gt ( F ) = 0.0591, wR ref ( F 2 ) = 0.1856, T = 293 K.

crystallography
Crystal Structure of N-(1-Benzyl-2-Oxoindolin-3-Yl)-N-P-Tolylbenzofuran-2-Carboxamide, C31h24n2o3

Wei-Wei Han,Jin-Long Wu

DOI: https://doi.org/10.1515/ncrs-2014-0021

2014-01-01

Abstract:C31H24N2O3, triclinic, P (1) over bar (no. 2), a = 7.9302(3) angstrom, b = 9.7234(7) angstrom, c = 15.671(1) angstrom, alpha = 86.070(5)degrees, beta = 83.134(4)degrees, gamma = 86.973(4)degrees, V = 1195.7 angstrom(3), Z = 2, R-gt(F) = 0.0475, wR(ref)(F-2) = 0.1205, T = 293 K.
Crystal structure of ( E )-2-(4-(1 H -imidazol-1-yl)benzylidene)-7-fluoro-3,4-dihydronaphthalen-1(2 H )-one, C 20 H 15 FN 2 O

Yu Chen,Ji-Peng Wang,Mei-Dan Wang,Wen-Xiao Yu,Yao-Tian Cui,Hao-Xue Gao,Gui-Ge Hou,Yan Ren

DOI: https://doi.org/10.1515/ncrs-2024-0294

2024-10-30

Zeitschrift für Kristallographie - New Crystal Structures

Abstract:C 20 H 15 FN 2 O, triclinic, P 1 ̅ (no. 2), a = 8.0724(1) Å, b = 9.6473(1) Å, c = 9.6635(1) Å, α = 80.903(1)°, β = 82.325(1)°, γ = 84.147(1)°, V = 733.922(14) Å 3 , Z = 2, R gt ( F ) = 0.0366, wR ref ( F 2 ) = 0.0934, T = 293 K.

crystallography
Crystal structure of 3,3,4,4,5,5-hexafluoro-1,2-bis{5-[2-(1,3-dithiocyclopentyl)]-2-methyl-3-thienyl} -cyclopent-1-ene, C21H18F6S6

Shouzhi Pu,L. Shen,J.-K. Xu,R.-J. Wang,Q. Xiao,Gang Liu

2004-01-01

Abstract:C21H18F6S6, triclinic, P (1) over bar (no. 2), a = 10.763(2) Angstrom, b = 10.871(2) Angstrom, c = 12.618(2) Angstrom, alpha = 112.75(1)degrees, beta = 100.61(1)degrees, gamma = 105.48(1)degrees, V = 1241.7 Angstrom(3), Z = 2, R-gt(F) = 0.071, wR(ref)(F-2) = 0.189, T = 293 K.
The crystal structure of ( E )-4-fluoro- N ′-(1-( o -tolyl)ethylidene)benzohydrazide, C 16 H 15 FN 2 O

Chuyi Wang,Xiaojing Dai,Guojun Tang,Wei Wang,Yang Zhao

DOI: https://doi.org/10.1515/ncrs-2023-0539

2024-02-23

Zeitschrift für Kristallographie - New Crystal Structures

Abstract:C 16 H 15 FN 2 O, monoclinic, Pc (no. 7), a = 12.3610(11) Å, b = 15.1269(17) Å, c = 8.1382(6) Å, β = 106.411(9)°, V = 1459.7(2) Å 3 , Z = 4, R gt ( F ) = 0.0565, wR ref ( F 2 ) = 0.1315, T = 293 K.

crystallography
Crystal structure of (1 E ,3 E ,5 E )-1,6-bis(4-(pentyloxy)phenyl)hexa-1,3,5-triene, C 28 H 36 O 2

Li Shen,Yu-Pei Xia,QingGuo Meng

DOI: https://doi.org/10.1515/ncrs-2024-0351

2024-10-17

Zeitschrift für Kristallographie - New Crystal Structures

Abstract:C 28 H 36 O 2 , monoclinic, P 2 1 / c (no. 14), a = 25.4751(13) Å, b = 7.4053(3) Å, c = 6.3520(3) Å, β = 93.923(5)°, V = 1,195.5(1) Å 3 , Z = 2, R gt ( F ) = 0.0650, wR ref ( F 2 ) = 0.2007, T = 298 K.

crystallography
Crystal structure of 3-(5-((4-(difluoromethoxy)phenyl) sulfonyl)-3,4,5,6-tetrahydropyrrolo[3,4- c ]pyrrol-2(1 H )-yl) oxetane-3-carboxamide, C 17 H 19 F 2 N 3 O 5 S

Bin Liu,Xiaona Xu,Hongjuan Tong,Yanjiao Wang,Zhoujing Zhu

DOI: https://doi.org/10.1515/ncrs-2023-0523

2024-02-15

Zeitschrift für Kristallographie - New Crystal Structures

Abstract:C 17 H 19 F 2 N 3 O 5 S, monoclinic, P2 1 /c (no. 14), a = 14.157(7) Å, b = 11.133(6) Å, c = 11.400(6) Å, β = 91.965(13)°, V = 1795.6(16) Å 3 , Z = 4, R gt (F) = 0.0611 wR ref (F 2 ) = 0.1809, T = 205 K.

crystallography
Crystal structure of 6,6′-((1 E ,1′ E )-((2-phenylpyrimidine-4,6-diyl)bis(hydrazin-2-yl-1-ylidene))bis(methaneylylidene))bis(2-methoxyphenol)monohydrate, C 26 H 26 N 6 O 5

Yating Hao,Pan Pan,Hairong Lan,Jiaxing Lu,Yan Wan,Yixin Chu

DOI: https://doi.org/10.1515/ncrs-2024-0109

2024-05-01

Zeitschrift für Kristallographie - New Crystal Structures

Abstract:C 26 H 26 N 6 O 5 , monoclinic, P 2 1 / c (no. 14), a = 10.9393(1) Å, b = 16.8724(2) Å, c = 13.5836(2) Å, β = 102.843(1)°, V = 2444.43(5) Å 3 , Z = 4, R gt ( F ) = 0.0318, wR ref ( F 2 ) = 0.0827, T = 173 K.

crystallography
Crystal structure of ( E )-6,8-dimethoxy-4-(4-morpholinobenzylidene)-3,4-dihydro-1-benzoxepin-5( 2H )-one, C 23 H 25 NO 5

De-Li Xia,Ji-Peng Wang,Wen-Xiao Yu,Mei-Dan Wang,Hao-Xue Gao,Yao-Tian Cui,Gui-Ge Hou

DOI: https://doi.org/10.1515/ncrs-2024-0329

2024-10-02

Zeitschrift für Kristallographie - New Crystal Structures

Abstract:C 23 H 25 NO 5 , monoclinic, Cc (no. 9), a = 21.2548(2) Å, b = 20.4713(1) Å, c = 16.7944(1) Å, β = 126.267(1)°, V = 5,891.79(10) Å 3 , Z = 12, R gt ( F ) = 0.0240, wR ref ( F 2 ) = 0.0649, T = 293 K.

crystallography

Crystal structure of (5 R ,8 R ,9 R ,10 R ,12 R , 13 R ,14 R ,17 S )-2-( E -3-fluorobenzylidene)-12-hydroxy-4,4,8,10,14-pentamethyl-17-(( R )-2,6,6-trimethyltetrahydro-2 H -pyran-2-yl) hexadecahydro-3 H -cyclopenta[ a ]phenanthren-3-one, C 37 H 53 FO 3

Crystal Structure of Ethyl 1-(4-fluorobenzyl)-3-phenyl-1h-pyrazole-5-carboxylate, C19H17FN2O2

Crystal structure of (8 R ,9 S ,10 R ,13 S ,14 S ,17 S )-17-hydroxy-10,13-dimethyl-17-((4-(2-phenylpropyl)phenyl)ethynyl)-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3 H -cyclopenta[ a ]phenanthren-3-one, C 36 H 42 O 2

Crystal Structure of 2-(1-benzyl-3-phenyl-1h-pyrazol-5-yl)-5-(4-nitrobenzylthio)-1,3,4-oxadiazole, C25H19N5O3S

Crystal Structure of Methyl 1-(4-fluorobenzyl)-3phenyl-1h-pyrazole-5-carboxylate, C18h15fn2o2

The Crystal Structure of (E)-3-chloro-2-(2-(2-fluorobenzylidene)hydrazinyl)pyridine, C12H9ClFN3

Crystal Structure of Ethyl 1-Benzyl-5-phenyl-1h-pyrazole-3-carboxylate, C19h18n2o2

Crystal Structure of 3,3,4,4,5,5-Hexafluoro-{1-[2-methyl-5- (4-Formylphenyl)-thien-3-yl]-2-[2-methyl-5-(4-(1,3-dioxolan- 2-Yl)phenyl)-thien-3-yl]}-cyclopent-1-ene, C31H22F6O3S2

Crystal structure of (2 S ,3 R ,4 S ,5 S ,6 R )-4,5-dihydroxy-6-(hydroxymethyl)-2-(((4 aS ,5 R ,6 S )-1-oxo-5-vinyl-4,4 a ,5,6-tetrahydro-1 H ,3 H -pyrano[3,4- c ]pyran-6-yl)oxy)tetrahydro-2 H -pyran-3-yl 2,3-dihydroxybenzoate hydrate, C 23 H 26 O 12 ·H 2 O

Crystal Structure of (Z)-2-(4-((5-bromopentyl)oxy)benzylidene)-4,5,6-trimethoxybenzofuran-3(2h)-one, C23H25BrO6

Crystal Structure of 3,3,4,4,5,5-Hexafluoro-1,2-bis(5-(3-trifluorophenyl)-2-methyl-3-thienyl) -Cyclopent-1-ene,c29h16f12s2

Crystal structure of 4,8a-bis(4-chlorophenyl)-1,5,6-tris(4-fluorobenzyl)-1,4,4a,4b,5,6,8a,8b-octahydrocyclobuta[1,2- b :3,4- c ′]dipyridine-3,8-dicarbonitrile, C 45 H 33 Cl 2 F 3 N 4

Crystal Structure of N-(1-Benzyl-2-Oxoindolin-3-Yl)-N-P-Tolylbenzofuran-2-Carboxamide, C31h24n2o3

Crystal structure of ( E )-2-(4-(1 H -imidazol-1-yl)benzylidene)-7-fluoro-3,4-dihydronaphthalen-1(2 H )-one, C 20 H 15 FN 2 O

Crystal structure of 3,3,4,4,5,5-hexafluoro-1,2-bis{5-[2-(1,3-dithiocyclopentyl)]-2-methyl-3-thienyl} -cyclopent-1-ene, C21H18F6S6

The crystal structure of ( E )-4-fluoro- N ′-(1-( o -tolyl)ethylidene)benzohydrazide, C 16 H 15 FN 2 O

Crystal structure of (1 E ,3 E ,5 E )-1,6-bis(4-(pentyloxy)phenyl)hexa-1,3,5-triene, C 28 H 36 O 2

Crystal structure of 3-(5-((4-(difluoromethoxy)phenyl) sulfonyl)-3,4,5,6-tetrahydropyrrolo[3,4- c ]pyrrol-2(1 H )-yl) oxetane-3-carboxamide, C 17 H 19 F 2 N 3 O 5 S

Crystal structure of 6,6′-((1 E ,1′ E )-((2-phenylpyrimidine-4,6-diyl)bis(hydrazin-2-yl-1-ylidene))bis(methaneylylidene))bis(2-methoxyphenol)monohydrate, C 26 H 26 N 6 O 5

Crystal structure of ( E )-6,8-dimethoxy-4-(4-morpholinobenzylidene)-3,4-dihydro-1-benzoxepin-5( 2H )-one, C 23 H 25 NO 5